Form D · Other Banking and Financial Services
PharmCo LLC
Phoenix, AZ · CIK 0001824318
Offering snapshot reported Oct 16, 2020 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Oct 3, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2020 | Initial | $5,000,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-378153
Source: Form D, filed Oct 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Stottlemyre | Executive, Promoter |
Issuer details
Industry: Other Banking and Financial Services (See others in industry)
Address:
3104 E. Camelback Rd. #2147
Phoenix, AZ, 85016
Phoenix, AZ, 85016